» Articles » PMID: 37870019

Comparative Study of Surgical Outcomes of Twin-site Phacotrabeculectomy with Mitomycin C in Primary Open-angle Glaucoma Versus Primary Angle-closure Glaucoma

Overview
Specialty Ophthalmology
Date 2023 Oct 23
PMID 37870019
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the surgical outcomes of twin-site phacotrabeculectomy with Mitomycin C (MMC) in primary open-angle glaucoma (POAG) versus primary angle-closure glaucoma (PACG).

Methods: Prospective, comparative, observational study. Patients with visually significant cataract and primary glaucoma were divided into two groups: POAG and PACG. They underwent twin-site phacotrabeculectomy with MMC and followed up on days 1, 15, 1 month, 6 months, and 12 months. Baseline and follow-up visits were compared to find the differences in intraocular pressure (IOP), antiglaucoma medications (AGM), success rates, anterior chamber depth (ACD), and axial length (AXL).

Results: There were 50 eyes each in POAG and PACG groups. Mean IOP reduction from baseline to 12 months (21.22 ± 6.0 to 11.40 ± 2.8-POAG group vs 24.16 ± 7.6 to 12.42 ± 3.2-PACG group) was statistically significant in both groups (P < 0.001), but no significant difference between groups (P = 0.095). There was a statistically significant decline in the number of AGM in POAG [1.66 (0.7) to 0.38 (0.7), P < 0.001] and PACG [2.10 (0.7) to 0.70 (0.8), P < 0.001]; the decline was more in POAG (P = 0.012) at last visit. Probability of overall (complete and qualified) success at 12 months postop was 72.0% [95% confidence interval (CI): 57.4-82.4] in PACG and 84.0% (95% CI: 70.5-91.7) in POAG group. There was a significant increase in ACD and a decrease in AXL in both groups (P < 0.001). More interventions were required in the PACG group (38, P = 0.012).

Conclusion: Phacotrabeculectomy with MMC causes a significant reduction in IOP and improvement in biometric parameters in both POAG and PACG. Patients with PACG required more postoperative interventions, while a lesser number of antiglaucoma medications were needed in POAG patients.

References
1.
Poon L, Lai I, Lee J, Tsai J, Lin P, Teng M . Comparison of surgical outcomes after phacotrabeculectomy in primary angle-closure glaucoma versus primary open-angle glaucoma. Taiwan J Ophthalmol. 2017; 5(1):28-32. PMC: 5602719. DOI: 10.1016/j.tjo.2015.01.001. View

2.
Vaideanu D, Mandal K, Hildreth A, Fraser S, Phelan P . Visual and refractive outcome of one-site phacotrabeculectomy compared with temporal approach phacoemulsification. Clin Ophthalmol. 2009; 2(3):569-74. PMC: 2694017. DOI: 10.2147/opth.s1764. View

3.
Migdal C, Gregory W, Hitchings R . Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994; 101(10):1651-6; discussion 1657. DOI: 10.1016/s0161-6420(94)31120-1. View

4.
Cunliffe I, Dapling R, West J, Longstaff S . A prospective study examining the changes in factors that affect visual acuity following trabeculectomy. Eye (Lond). 1992; 6 ( Pt 6):618-22. DOI: 10.1038/eye.1992.133. View

5.
. The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol. 2001; 119(12):1771-9. DOI: 10.1001/archopht.119.12.1771. View